http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102908584-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85b69c09badcde02750c9dfdebcc0494 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A47G9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08 |
| filingDate | 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae2e153ee817d4910909262c6e3a0eb6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fa2110ed893320d726078b0ed29dfd5 |
| publicationDate | 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102908584-B |
| titleOfInvention | Traditional Chinese medicine composition for treating cervical spondylosis |
| abstract | A traditional Chinese medicine composition for treating cervical spondylosis is prepared by the following raw material medicines in parts by weight: 25 to 40 parts of caulis erycibes, 20 to 30 parts of euonymus alatus, 15 to 25 parts of caesalpinia minax hance, 5 to 10 parts of feculae bombycis, 5 to 15 parts of turpentine, 10 to 25 parts of lamiophlomis rotate, 10 to 30 parts of radix zanthoxyli, 20 to 30 parts of radix alangii, 15 to 30 parts of radix clematidis, 10 to 25 parts of caulis piperis kadsurae, 20 to 30 parts of rhizoma homalomenae, 10 to 20 parts of snow lotus, 10 to 25 parts of radix curcumae longae, 15 to 30 parts of pyrite, 10 to 20 parts of sanguis draconis and 15 to 30 parts of rhizoma curcumae. With the adoption of the traditional Chinese medicine composition provided by the invention, the cervical spondylosis is specifically treated; The traditional Chinese medicine composition for treating the cervical spondylosis is good in efficacy, high in cure rate, short in course of treatment and free from pain; and furthermore, the raw materials in the market are sufficient, the price is cheap, and the raw materials are harmless and nontoxic to human bodies, safe and reliable in administration, and free from side effects, thereby being applied to the crowds with the different degrees of the conditions of the patients. |
| priorityDate | 2012-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451160908 |
Total number of triples: 17.